Natural killer cells produced from induced pluripotent stem cells, method for producing same, and use thereof
AssigneeTherabest Co., Ltd
InventorsShin-Il Kim, Do Won Hwang, Young Wook Ki
Life of this patent
Estimating the term…
Loading patent…
AssigneeTherabest Co., Ltd
InventorsShin-Il Kim, Do Won Hwang, Young Wook Ki
Estimating the term…
The present invention relates to: natural killer cells produced and mass-proliferated from induced pluripotent stem cells; and a pharmaceutical composition comprising the same as an active ingredient. The natural killer cells according to the present invention exhibited oncolytic activity at cellular and animal levels. In addition, the expression of genes and cytokines involved in tumor death and immune cell activity was increased compared to natural killer cells isolated from blood and activated. It was also confirmed that a method for inducing differentiation of natural killer cells derived from induced pluripotent stem cells, according to the present invention, is a method for producing a large number of cells within a short period of time by using a simple method compared to conventional induction methods using induced pluripotent stem cells. Therefore, it is considered that a method for differentiating natural killer cells derived from induced pluripotent stem cells, and natural killer cells produced by the method, according to the present invention, can be used in the treatment of various diseases, including cancer.
A natural killer cell expressing any one protein selected from the group consisting of CD25, CD9, CD80, and a combination thereof.
A method for producing natural killer cells, comprising:
A method for culturing stem cells, comprising:
A method for producing natural killer cells, comprising:
Dependencies are inferred from the claim text.